Allan Rosetzsky
Directeur Général chez AR Consult ApS
Profil
Allan Rosetzsky is the founder of KLIFO A (1994) and AR Consult ApS (1995), where he holds the title of Chief Executive Officer & Chairman.
He currently holds positions as Chairman at Hepoligo Solutions ApS, Director at ExpreS2ion Biotechnologies ApS and GlyProVac ApS, and Director at Adaptvac ApS (since 2020).
Dr. Rosetzsky's former positions include Chairman at Interface Biotech A, Medical Director at Rhone-Poulenc Pharma GmbH, and Director at Expres2ion Biotech Holding AB (2010-2022).
Dr. Rosetzsky earned a doctorate degree from the University of Copenhagen in 1973.
Postes actifs de Allan Rosetzsky
| Sociétés | Poste | Début |
|---|---|---|
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Directeur/Membre du Conseil | 26/04/2011 |
| Adaptvac ApS | Directeur/Membre du Conseil | 01/01/2020 |
AR Consult ApS
 AR Consult ApS Information Technology ServicesTechnology Services AR Consult ApS is a company based in Hørsholm, Denmark that was founded in 2008 by Allan Rosetzsky. The Danish company offers expertise in clinical research and development for the pharma and biotech industries, as well as guidance for venture capital investors in these companies. The company provides medical advice on protocols, development plans, licensing opportunities, due diligence, business angel gatekeeper, and translations collaborations. Additionally, they offer regulatory advice through Jacobsen Advice and are affiliated with the venture capital association DVCA and the business angel association BA-Copenhagen. Allan Rosetzsky has been the CEO since 1995. | Directeur Général | 09/03/1995 |
Hepoligo Solutions ApS
 Hepoligo Solutions ApS BiotechnologyHealth Technology Hepoligo Solutions ApS provides synthesis technology for development of heparin derivatives. Its services include chemical consultant work, heparin derivatives, and intermediaries. The company was founded by Hansen Steen Uldall and Svennesen Tom Koch and is headquartered in Aabenraa, Denmark. | Président | - |
GlyProVac ApS
 GlyProVac ApS Packaged SoftwareTechnology Services GlyProVac ApS engages in mastering an immensely promising mapping technology. It offers funding, technology and intellectual property. The company was founded by Anders Boysen and Ann Zahle Andersen in 2018 and is headquartered in Odense, Denmark. | Directeur/Membre du Conseil | - |
Anciens postes connus de Allan Rosetzsky
| Sociétés | Poste | Fin |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Directeur/Membre du Conseil | 06/10/2022 |
Interface Biotech A/S
 Interface Biotech A/S Pharmaceuticals: MajorHealth Technology Interface Biotech A/S develops products for the treatment of cartilage and bone disorders. The firm also offers cGMP culturing of human cells for implantation and research services. The company was founded in 1998 by Kurt Osther and is headquartered in Hoersholm, Denmark. | Président | 01/04/2010 |
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Fondateur | 01/12/2007 |
| Rhone-Poulenc Pharma GmbH | Directeur Technique/Scientifique/R&D | - |
Formation de Allan Rosetzsky
| University of Copenhagen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| Entreprise privées | 8 |
|---|---|
KLIFO A/S
KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Interface Biotech A/S
Interface Biotech A/S Pharmaceuticals: MajorHealth Technology Interface Biotech A/S develops products for the treatment of cartilage and bone disorders. The firm also offers cGMP culturing of human cells for implantation and research services. The company was founded in 1998 by Kurt Osther and is headquartered in Hoersholm, Denmark. | Health Technology |
| Rhone-Poulenc Pharma GmbH | |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
AR Consult ApS
AR Consult ApS Information Technology ServicesTechnology Services AR Consult ApS is a company based in Hørsholm, Denmark that was founded in 2008 by Allan Rosetzsky. The Danish company offers expertise in clinical research and development for the pharma and biotech industries, as well as guidance for venture capital investors in these companies. The company provides medical advice on protocols, development plans, licensing opportunities, due diligence, business angel gatekeeper, and translations collaborations. Additionally, they offer regulatory advice through Jacobsen Advice and are affiliated with the venture capital association DVCA and the business angel association BA-Copenhagen. Allan Rosetzsky has been the CEO since 1995. | Technology Services |
Hepoligo Solutions ApS
Hepoligo Solutions ApS BiotechnologyHealth Technology Hepoligo Solutions ApS provides synthesis technology for development of heparin derivatives. Its services include chemical consultant work, heparin derivatives, and intermediaries. The company was founded by Hansen Steen Uldall and Svennesen Tom Koch and is headquartered in Aabenraa, Denmark. | Health Technology |
GlyProVac ApS
GlyProVac ApS Packaged SoftwareTechnology Services GlyProVac ApS engages in mastering an immensely promising mapping technology. It offers funding, technology and intellectual property. The company was founded by Anders Boysen and Ann Zahle Andersen in 2018 and is headquartered in Odense, Denmark. | Technology Services |
| Adaptvac ApS |